Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 3
1987 3
1988 2
1989 2
1991 1
1992 1
1993 1
1994 4
1995 2
1996 1
1997 2
1998 3
2000 1
2001 2
2002 1
2005 1
2006 2
2007 1
2008 2
2009 4
2010 1
2011 2
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed (OMIM) for id: 1557

40 results

Results by year

Filters applied: . Clear all
Page 1
CYP2C19 genotype and outcomes of clopidogrel treatment.
Geisler T, Bigalke B, Schwab M. Geisler T, et al. N Engl J Med. 2011 Feb 3;364(5):481; author reply 482. doi: 10.1056/NEJMc1013331. N Engl J Med. 2011. PMID: 21288102 No abstract available.
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.
Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KA, Eikelboom JW. Paré G, et al. N Engl J Med. 2010 Oct 28;363(18):1704-14. doi: 10.1056/NEJMoa1008410. Epub 2010 Aug 29. N Engl J Med. 2010. PMID: 20979470 Free article. Clinical Trial.
Cytochrome P-450 polymorphisms and response to clopidogrel.
Taubert D, Bouman HJ, van Werkum JW. Taubert D, et al. N Engl J Med. 2009 May 21;360(21):2249-50; author reply 2251. doi: 10.1056/NEJMc090391. N Engl J Med. 2009. PMID: 19458375 Free article. No abstract available.
Cytochrome p-450 polymorphisms and response to clopidogrel.
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Mega JL, et al. N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22. N Engl J Med. 2009. PMID: 19106084 Free article.
Genetic determinants of response to clopidogrel and cardiovascular events.
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Simon T, et al. N Engl J Med. 2009 Jan 22;360(4):363-75. doi: 10.1056/NEJMoa0808227. Epub 2008 Dec 22. N Engl J Med. 2009. PMID: 19106083 Free article.
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Valente S, Antoniucci D, Abbate R, Gensini GF. Giusti B, et al. Pharmacogenet Genomics. 2007 Dec;17(12):1057-64. doi: 10.1097/FPC.0b013e3282f1b2be. Pharmacogenet Genomics. 2007. PMID: 18004210
40 results